| [1] |
Algahtani FH, Alqahtany FS, Al-Shehri A, et al. Features and incidence of thromboembolic disease: a comparative study between high and low altitude dwellers in Saudi Arabia[J]. Saudi J Biol Sci, 2020, 27: 1632-1636.
|
| [2] |
Yanamandra U, Boddu R, Pramanik S, et al. Prevalence and clinical characteristics of post-thrombotic syndrome in high-altitude-induced deep vein thrombosis: experience of a single tertiary care center from real-world settings[J]. High Alt Med Biol, 2020, 21: 319-326.
|
| [3] |
Li M, Tang X, Liao Z, et al. Hypoxia and low temperature upregulate transferrin to induce hypercoagulability at high altitude[J]. Blood, 2022, 140: 2063-2075.
|
| [4] |
Wang Z, Tenzing N, Xu Q, et al. Apoptosis is one cause of thrombocytopenia in patients with high-altitude polycythemia[J]. Platelets, 2023, 34: 2157381. doi:10.1080/09537104.2022.2157381.
|
| [5] |
Licker M, Hagerman A, Jeleff A, et al. The hypoxic pulmonary vasoconstriction: from physiology to clinical application in thoracic surgery[J]. Saudi J Anaesth, 2021, 15: 250-263.
|
| [6] |
Santolicandro A, Prediletto R, Fornai E, et al. Mechanisms of hypoxemia and hypocapnia in pulmonary embolism[J]. Am J Respir Crit Care Med, 1995, 152: 336-347.
|
| [7] |
Gao J, Zhang Z, Yan JY, et al. Inflammation and coagulation abnormalities via the activation of the HMGB1-RAGE/NF-κB and F2/Rho pathways in lung injury induced by acute hypoxia[J]. Int J Mol Med, 2023, 52: 67-82
|
| [8] |
Nishimura T, Motoi M, Toyoshima H, et al. Endocrine, inflammatory and immune responses and individual differences in acute hypobaric hypoxia in lowlanders[J]. Sci Rep, 2023, 13: 12659. doi:10.1038/s41598-023-39894-w.
|
| [9] |
Sadia K, Ashraf MZ, Mishra A. Therapeutic role of sirtuins targeting unfolded protein response, coagulation, and inflammation in hypoxia-induced thrombosis[J]. Front Physiol, 2021, 12: 733453. doi:10.3389/fphys.2021.733453.
|
| [10] |
Zhang M, Gao J, Zhao X, et al. p38α in macrophages aggravates arterial endothelium injury by releasing IL-6 through phosphorylating megakaryocytic leukemia 1[J]. Redox Biol, 2021, 38: 101775. doi:10.1016/j.redox.2020.101775.
|
| [11] |
Eljilany I, Elzouki AN. D-dimer, fibrinogen, and IL-6 in COVID-19 patients with suspected venous thromboembolism: a narrative review[J]. Vasc Health Risk Manag, 2020, 16: 455-462.
|
| [12] |
Eslamifar Z, Behzadifard M, Soleimani M, et al. Coagulation abnormalities in SARS-CoV-2 infection: overexpression tissue factor[J]. Thromb J, 2020, 18: 38-41.
|
| [13] |
Li MC, He SH. IL-10 and its related cytokines for treatment of inflammatory bowel disease[J]. World J Gastroenterol, 2004, 10: 620-625.
|
| [14] |
Xue M, Qiqige C, Zhang Q, et al. Effects of tumor necrosis factor α (TNF-α) and interleukina 10 (IL-10) on intercellular cell adhesion molecule-1 (ICAM-1) and cluster of differentiation 31 (CD31) in human coronary artery endothelial cells[J]. Med Sci Monit, 2018, 24: 4433-4439.
|
| [15] |
崔金霞, 张永东, 时莹庆, 等. 高海拔COPD大鼠血浆TNF-α、IL-6和IL-10水平升高[J]. 基础医学与临床, 2014, 34: 1108-1109.
|